Psyence Biomedical Ltd. (NASDAQ:PBM) does about 3.78M shares in volume on a normal day but saw 12197186 shares change hands in the recent trading day. The company now has a market cap of 2.00M USD. Its current market price is $0.12, marking a decrease of -6.11% compared to the previous close of $0.13. The 52 week high reached by this stock is $14.55 whilst the lowest price level in 52 weeks is $0.12.
Psyence Biomedical Ltd. (PBM) has a 20-day trading average at $0.2583 and the current price is -99.18% off the 52-week high compared with 2.39% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.4006. If we look at the stock’s price movements over the week, volatility stands at 17.46%, which decreases to 15.53% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 18.46 to suggest the stock is oversold.
The current price level is -56.93%, -70.38%, and -95.12% away from its SMA20, SMA50, and SMA200 respectively, with the PBM price moving above the 50-day SMA on current market day. Psyence Biomedical Ltd. (PBM) stock is down -23.14% over the week and -76.94% over the past month. Its price is -98.70% year-to-date and -98.83% over the past year.
Outstanding shares total 13.39M with insiders holding 58.48% of the shares and institutional holders owning 13.24% of the company’s common stock. The company has a return on equity of 1.27%. The beta has a value of -0.40.
